Cargando…
Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma
Given the crucial role of microRNAs in the cellular proliferation of various types of cancers, we aimed to analyze the expression and function of a cellular proliferation-associated miR-188-5p in papillary thyroid carcinoma (PTC). Here we demonstrate that miR-188-5p is downregulated in PTC tumor tis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586257/ https://www.ncbi.nlm.nih.gov/pubmed/32425116 http://dx.doi.org/10.1177/0963689720918300 |
_version_ | 1783599958271721472 |
---|---|
author | Zhou, Ping Irving, Andrew Wu, Huifang Luo, Juan Aguirre, Johana Costa, Mariana Khamsuree, Monny Gerads, Natascha Liu, Weibang |
author_facet | Zhou, Ping Irving, Andrew Wu, Huifang Luo, Juan Aguirre, Johana Costa, Mariana Khamsuree, Monny Gerads, Natascha Liu, Weibang |
author_sort | Zhou, Ping |
collection | PubMed |
description | Given the crucial role of microRNAs in the cellular proliferation of various types of cancers, we aimed to analyze the expression and function of a cellular proliferation-associated miR-188-5p in papillary thyroid carcinoma (PTC). Here we demonstrate that miR-188-5p is downregulated in PTC tumor tissues compared with the associated noncancerous tissues. We also validate that the miR-188-5p overexpression suppressed the PTC cancer cell proliferation. In addition, fibroblast growth factor 5 (FGF5) is observed to be downregulated in the PTC tumor tissues compared with the associated noncancerous tissues. Subsequently, FGF5 is identified as the direct functional target of miR-188-5p. Moreover, the silencing of FGF5 was found to inhibit PTC cell proliferation, which is the same pattern as miR-188-5p overexpression. These results suggest that miR-188-5p-associated silencing of FGF5 inhibits tumor cell proliferation in PTC. It also highlights the importance of further evaluating miR-188-5p as a potential biomarker and therapy target in PTC. |
format | Online Article Text |
id | pubmed-7586257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75862572020-11-03 Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma Zhou, Ping Irving, Andrew Wu, Huifang Luo, Juan Aguirre, Johana Costa, Mariana Khamsuree, Monny Gerads, Natascha Liu, Weibang Cell Transplant Cancer Pharmacogenomics and Target Therapy - Original Article Given the crucial role of microRNAs in the cellular proliferation of various types of cancers, we aimed to analyze the expression and function of a cellular proliferation-associated miR-188-5p in papillary thyroid carcinoma (PTC). Here we demonstrate that miR-188-5p is downregulated in PTC tumor tissues compared with the associated noncancerous tissues. We also validate that the miR-188-5p overexpression suppressed the PTC cancer cell proliferation. In addition, fibroblast growth factor 5 (FGF5) is observed to be downregulated in the PTC tumor tissues compared with the associated noncancerous tissues. Subsequently, FGF5 is identified as the direct functional target of miR-188-5p. Moreover, the silencing of FGF5 was found to inhibit PTC cell proliferation, which is the same pattern as miR-188-5p overexpression. These results suggest that miR-188-5p-associated silencing of FGF5 inhibits tumor cell proliferation in PTC. It also highlights the importance of further evaluating miR-188-5p as a potential biomarker and therapy target in PTC. SAGE Publications 2020-05-19 /pmc/articles/PMC7586257/ /pubmed/32425116 http://dx.doi.org/10.1177/0963689720918300 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Cancer Pharmacogenomics and Target Therapy - Original Article Zhou, Ping Irving, Andrew Wu, Huifang Luo, Juan Aguirre, Johana Costa, Mariana Khamsuree, Monny Gerads, Natascha Liu, Weibang Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title | Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title_full | Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title_fullStr | Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title_full_unstemmed | Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title_short | Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma |
title_sort | validation of microrna-188-5p inhibition power on tumor cell proliferation in papillary thyroid carcinoma |
topic | Cancer Pharmacogenomics and Target Therapy - Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586257/ https://www.ncbi.nlm.nih.gov/pubmed/32425116 http://dx.doi.org/10.1177/0963689720918300 |
work_keys_str_mv | AT zhouping validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT irvingandrew validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT wuhuifang validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT luojuan validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT aguirrejohana validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT costamariana validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT khamsureemonny validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT geradsnatascha validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma AT liuweibang validationofmicrorna1885pinhibitionpowerontumorcellproliferationinpapillarythyroidcarcinoma |